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Abstract
Background: In Hong Kong, people aged 50–64 years were added as a recommended priority group (recommended
group) for influenza vaccination by the Department of Health (DH) starting from 2011/12 onwards. The coverage rate
of influenza vaccination for this age group was suboptimal at 8.5 % in 2012/13. This study investigates the factors
associated with the uptake of influenza vaccination among adults in Hong Kong aged 50–64 years.
Methods: A case–control study was conducted in communities by street intercept interviews from 17 July to 15
August 2013. Cases were adults aged 50–64 years who had received the influenza vaccine in 2011/12 or 2012/13,
while controls were the same as the cases, except they had not received the influenza vaccine in 2011/12 or 2012/13.
Multiple logistic regression analysis was performed on the data to explore the associations between vaccination status
and the variables.
Results: Six hundred and four respondents in total were interviewed and included in the analysis. There were 193 cases
(vaccinated) and 411 controls (non-vaccinated), with a case-to-control ratio of 1:2.1. The following were strongly associated
with vaccination compared to other factors: ‘eligible for free government vaccine’ (OR6.38, 95 % CI, 3.43-11.87, p < 0.001);
‘willing to receive flu vaccination for free’ (OR4.84, 95 % CI, 2.13-11.03, p < 0.001); ‘perceived having severe or moderate
symptoms when contracting flu’ (OR2.90, 95 % CI, 1.21-6.97, p = 0.02), and ‘convenient to reach a vaccination location’
(OR2.87, 95 % CI, 1.06-7.74, p = 0.04). The majority of the cases (80.8 %) and controls (93.9 %) were not aware that they
belonged to a recommended group for influenza vaccination and most (>80 %) were willing to be vaccinated if it
was free.
Conclusions: Factors related to free and convenient vaccination, the perception of the severity of symptoms when
contracting influenza had a comparatively strong association with influenza vaccination uptake amongst 50–64 year olds,
compared to other factors.
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Background
Seasonal influenza vaccination (referred to as ‘influenza
vaccination’, ‘vaccination’ or ‘vaccine’, below) remains an
effective measure to protect individuals and communi-
ties from severe morbidity and mortality induced by in-
fluenza. To mitigate the disease burden of influenza,
many developed countries recommend vaccination for
high-risk groups. Some exceptions are the United States
(US), Austria and Estonia, which have universally recom-
mended people aged 6 months or above to receive influ-
enza vaccination [1–3]. Few European countries, such as
Belgium and Ireland, included those aged 50–64 years in
their recommended groups [4].
Although the vaccine did not provide an overall eco-
nomic benefit in some communities, it yielded signifi-
cant health benefits by reducing severe complications
from influenza [3, 5, 6]. Meta-analysis and literature re-
views demonstrated that the influenza vaccine had a
moderate effect in reducing the clinical symptoms of in-
fluenza in healthy people from 16 to 64 years [7, 8].
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Many middle-aged adults have undiagnosed medical
conditions, such as diabetes mellitus, and are at higher
risk of severe influenza-related complications [9, 10].
In Hong Kong, people aged 50–64 years were added
as a recommended priority group (recommended group)
for influenza vaccination by the Department of Health
(DH) starting from 2011/12 [11]. The major driver be-
hind this inititiative was a real increase in influenza-
attributed Intensive Care Unit (ICU) admissions and
deaths among the middle-aged group in 2010/11, [7]
plus an anticipated increase in the years to come when
the influenza A(H1N1)pdm09 strain was predicted to
circulate in the population.
After this new vaccination policy was launched, how-
ever, the vaccine was not well received and the vaccination
coverage in this new target group was very low at 8.5 %
[12]. No free or subsidised influenza vaccination service
was provided by the Government to this group, except
those who already belonged to the other free or subsidised
recommended high-risk groups and those with financial
difficulties, i.e., Comprehensive Social Security Assistance
(CSSA) recipients. Healthy 50–64 year olds, without other
risk indicators, had to pay if they wanted to be vaccinated.
This study aimed to find out which factors were associated
with the low uptake of influenza vaccination among
people aged 50–64 years in Hong Kong.
Methods
A survey was conducted in a community setting in
Hong Kong from 17 July to 15 August 2013, following
which a case–control analysis was used to investigate
the study hypothesis. Street intercept interviews were
undertaken in 6 districts (out of a total of 18 in the terri-
tory). Cases were (i) those who received the influenza
vaccine in 2011/12 or 2012/13, i.e., from 1 September
2011 to 31 August 2013; (ii) aged 50–64 years in 2012–
2013; and (iii) citizens who were resident in Hong Kong.
Controls were the same as the cases in (ii) and (iii), except
they had not received the influenza vaccine in 2011/12 or
2012/13 influenza seasons. Some controls had received
the influenza vaccine before 1 September 2011. They were
classified as control because they were not included as the
recommended group in 2010/11 and before.
The sample size was calculated with a significance
level of 0.05 (two-sided) and a power level of 0.80. The
calculation of the sample size was done by the Fleiss for-
mula for unmatched case–control studies with dichot-
omous exposure variables. A minimum sample size of
510 was required with a case-to-control ratio of 1:2 [13].
The interviewers were assigned a random time slot,
covering weekdays, weekends, office and non-office
hours. The questionnaire was conducted in summer
2013 before the next influenza vaccination season, which
usually begins in September of each year. Primary data
were collected by four trained research interviewers who
were fluent in Chinese and English. The interviewers
were stationed in areas of high pedestrian traffic, such as
near underground train stations and shopping malls,
during the assigned random time slot.
This research had been approved by the Human
Subjects Ethics Sub-committee of the Hong Kong
Polytechnic University and the Ethics Committee of the
London School of Hygiene and Tropical Medicine. Be-
fore each interview, the interviewer would inform the re-
spondent about the nature and purpose of the study and
invited their voluntary participation. Interviewees were
asked to respond only after informed consent was ob-
tained. No incentive was given.
The hypothesis of this study was there were differences
in associated factors (variables) between those Hong Kong
residents aged 50–64 years who received the influenza
vaccine in 2011/12 and 2012/13, and those who did not.
The Null hypothesis assumes no such association.
The questionnaire was designed with reference to past
vaccination questionnaires from health authorities [14, 15]
and relevant studies [16–18]. The draft questionnaire was
then sent for comment to a multi-disciplinary team, com-
prised of an infectious disease specialist, an epidemiologist
and general practitioners. The questionnaire was in
Chinese and English and had 38 questions including 11 on
demographic data and 27 covering the factors (variables)
to be examined.
Statistical analyses were performed using the software
SAS 9.3. Categorical demographic data and variables
were compared using the Pearson chi-square test, crude
and adjusted odds ratios (ORs) with corresponding 95 %
confidence intervals (CIs) and p-values. Multiple logistic
regression analysis was performed. Any variables with p
values <0.25 and those with important associations dem-
onstrated in the literature were selected for regression
analysis (backward stepwise regression algorithms). The
regression model is a built-in formula in the SAS software.
All statistical tests were two-tailed and variables were con-
sidered significant at a significance level of 0.05.
Results
The study included 193 cases (vaccinated) and 411 con-
trols (non-vaccinated), with a case to control ratio of
1:2.1. This sample size reached the required range in the
sample size calculation. The average interview time was
7 min (standard deviation ±4 min) for each question-
naire, and the response rate was 41.7 %. During street
intercept interviews, there were more non-vaccinated in-
dividuals (controls) than vaccinated ones (cases). After
the required number of non-vaccinated was recruited,
the excess approached by the interviewers were counted
as non-responders. In total 210 man-hours were spent
on the interviews.
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Demography
The differences between baseline demographic data of
cases and controls were statistically insignificant regarding
sex, ethics, education level, employment status, personal
monthly income, current smoking and drinking status. The
demography of cases and controls are shown in Table 1.
There was no apparent discrepancy in the sample and
the target population. One exception was in the sampled
respondents; there were proportionally higher numbers
of females than males (M:F = 1:1.6), while the overall ra-
tio in the target community was 1:1. Other demographic
parameters of the sampled population, such as the age
proportion between groups, education level, ethnicity,
and the percentage of those in employment, were com-
parable to the target population (i.e., Hong Kong general
population aged 50–64 years).
The majority of the respondents were Chinese, and
there were more female than male respondents (38.4 %
vs 61.6 %). Most (86.5 %) of those who were in employ-
ment were aged 59 years or below. Overall, half of the
respondents (51.5 %) had no income. One in four
(26.3 %) was a housewife and one fifth (20.0 %) was re-
tired. The majority of them (71.5 %) had received at least
9 years of education up to secondary level.
Health knowledge related to influenza vaccine
The majority of all the cases (80.8 %) and controls
(93.9 %) were not aware that the health authority had
recommended vaccination against influenza. However,
the cases were more aware of the recommendation for
influenza vaccination than the controls, (OR2.34, 95 %
CI 1.23-4.44, p = 0.009). There were health knowledge
differences between the cases and controls in all the
questions asked on knowledge, including government
vaccination services, vaccine reduction in influenza-
related hospital admission, and vaccine protection for
healthy adults. However, these associations were statisti-
cally insignificant after the OR was adjusted (Table 2).
Health needs
When compared to the controls, more of the cases had
chronic diseases; more frequently ‘visited doctors in the
past 3 months’ and ‘lived with children below 6 years or el-
ders above 65 years’. However, none of these associations
was statistically significant after the OR was adjusted.
Health behaviours
There was no association between vaccination and smok-
ing/drinking. Most cases (85.4 %) stated that they were
likely or very likely to receive the vaccine in 2013/14, com-
pared to only 29.4 % among the controls. This implies
those who had previous vaccinations in 2010/11 and 2011/
12 would choose to be vaccinated again in the future.
Health belief and perception
In general, more cases perceived there to be a higher
risk of contracting influenza in the next 12 months and/
or having severe influenza or moderate symptoms when
Table 1 Demography of the cases and controls
Case (n = 193) Control (n = 411) Crude odd ratio (OR)
No. % No. % OR 95 % CI p-value*
Average age (mean year) ± SD** 57.3 ± 4.8 56.3 ± 4.4 - - -
Sex Male 73 37.8 159 38.7 1 ref*** ref
Female 120 62.2 252 61.3 1.04 0.73 1.48 0.84
Age group 50 - 54 59 30.6 176 42.8 1 ref ref
55 - 59 63 32.6 119 29.0 1.58 1.03 2.41 0.04
60 - 64 71 36.8 116 28.2 1.83 1.20 2.77 0.005
Ethnic Chinese 193 100.0 410 99.8 - - -
Education Primary or below 58 30.1 110 26.8 1 ref ref
Secondary 120 62.2 260 63.9 0.88 0.60 1.29 0.50
Tertiary or above 15 7.8 37 9.1 0.77 0.39 1.52 0.46
Status Retired 52 26.9 69 16.8 - - -
Housewife 47 24.4 112 27.3 - - -
Employed Yes 83 43.0 198 48.2 0.82 0.58 1.15 0.24
No 110 57.0 213 51.8 1 ref ref
Current smoker Yes 16 8.3 20 4.9 1.77 0.89 3.49 0.11
No 177 91.7 391 95.1 1 ref ref
*p-value is the value of crude OR when compared to reference
**standard deviation
***ref is reference
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compared to the controls. Vaccination was perceived
more positively by the cases than the controls. More
cases than controls ‘perceived flu vaccine to be safe’ and
‘believed flu vaccine has additional benefits other than
flu protection’. However, the only statistically significant
variable was ‘perception of severe or moderate symp-
toms when contracting flu’ with an OR of 2.90 (95 % CI
1.21-6.97, p = 0.02).
Health-care system
There was an association between ‘eligible for free gov-
ernment vaccine’ and vaccination (OR6.38, 95 % CI
3.43-11.87, p < 0.001). When compared with controls,
more cases were ‘willing to receive flu vaccination for
free’ (OR4.84, 95 % CI 2.13-11.03, p < 0.001). Ninety-five
percent (95.8 %) of the cases and 75 % (75.7 %) were
‘willing to receive flu vaccination for free’. Cases had a
higher likelihood of being able to access a convenient lo-
cation for vaccination (OR2.87, 95 % CI 1.06-7.74, p =
0.04). Fewer cases preferred to go to a public clinic for
an injection (OR0.35, 95 % CI 0.22-0.55, p < 0.001).
There were no associations between differences in re-
sponse to the government telephone reminder service
for vaccination, if there was one.
Advice
In respect of vaccination, the cases were more heavily
influenced by others’ opinions and actions than were the
controls. When compared, more cases would ‘accept ad-
vice from health professionals’ (OR2.67, 95 % CI 1.19-
Table 2 Comparing study variables between cases and controls by adjusted odds ratios*
Cases (193) Control (411) Odds ratio (Adjusted)
Count % Count % value 95 % CI p-value
Knowledge
Knowing oneself to be in the recommended group for flu vaccine 37 19.6 25 6.1 2.34 1.23 4.44 0.01
Knowing flu vaccine provides 70–90 % protection in healthy adults 89 46.6 140 34.1 1.86 1.12 3.10 0.02
Knowing about the Government Vaccination Programme 128 68.0 219 53.5 1.09 0.68 1.75 0.72
Knowing flu vaccine reduces flu complications and related hospitalisation 180 97.8 366 93.4 0.89 0.25 3.19 0.86
Needs
Live with children < 6 years or elderly >65 years 53 27.5 85 20.7 1.23 0.74 2.04 0.43
Presence of chronic disease(s) 78 40.4 111 27.1 1.13 0.65 1.96 0.67
Visited doctors in the past 3 months 92 47.7 141 34.3 1.12 0.67 1.87 0.68
Behaviour
Current smoker 16 8.3 20 4.9 0.72 0.27 1.92 0.52
Current drinker 34 17.6 80 19.5 - - - -
Belief & perception
Perceived having severe or moderate symptoms when contracting flu 17 8.8 15 3.6 2.90 1.21 6.97 0.02
Perceived flu vaccine to be safe 183 98.4 342 89.8 3.99 0.78 20.41 0.10
Believed flu vaccine has additional benefits other than flu protection 181 93.8 356 87.3 1.36 0.58 3.21 0.48
Health-care system
Eligible for free government vaccine 45 23.6 21 5.1 6.38 3.43 11.87 <0.001
Willing to receive flu vaccination for free 184 95.8 309 75.7 4.84 2.13 11.03 <0.001
Convenient to reach a vaccination location 187 96.9 370 90.0 2.87 1.06 7.74 0.04
Prefer public clinic for injection 105 54.7 291 71.0 0.35 0.22 0.55 <0.001
Will respond to Government telephone reminder service on flu shot 105 54.4 160 39.6 0.84 0.51 1.38 0.49
Advice
Accept advice from health professionals 183 94.8 333 81.2 2.67 1.19 5.99 0.02
Had family member receive flu vaccine 76 41.8 74 18.3 2.47 1.54 3.95 <0.001
Accept advice from relatives and friends 86 44.8 101 24.6 1.47 0.84 2.56 0.18
External factors
Will receive flu vaccine when there is an epidemic 181 94.8 327 81.3 2.40 1.07 5.37 0.03
*All study variables in this table are binary categorical variables (yes/no) with the ‘no’ category being used as the reference group for calculating ORs. Statistically
significant odds ratios (adjusted) are bold.
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5.99, p = 0.02); and ‘family members who had received
the flu vaccine’ than the controls (OR2.47, 95 % CI 1.54-
3.95, p < 0.001).
External factors
External factors refer to unpredictable environmental
factors, such as the occurrence of disease epidemics like
Severe Acute Respiratory Syndrome (SARS) or pandemic
influenza. High percentages of both cases (94.8 %) and
controls (81.3 %) would receive a vaccine when there
was a disease epidemic. When compared, more cases
would receive a vaccine during an epidemic and the OR
was 2.40 (95 % CI 1.07-5.37, p = 0.03).
Additional information
Among the controls (i.e., never received vaccination or
received vaccine on or before 2009/10), 25.6 % of them
had previously received the vaccine. The following were
common reasons given by the controls for not receiving
a vaccine: considered vaccination unnecessary (70.8 %);
believed they were not in a high-risk group (37.0 %); and
concerns about side effects of vaccination (19.0 %). Of
the controls that had previously been vaccinated, 59 %
had received the vaccine at a public clinic.
A subgroup analysis was performed on those who re-
ceived influenza vaccination but did not know they were
recommended group by the Department of Health (DH).
There were 193 cases (who were vaccinated) and among
them 37 answered yes to “knowing oneself to be in the
recommended group for flu vaccine” and 156 answered
no. In these 156 people the five commonest reasons for
vaccination were: advice from healthcare professionals
(58.8 %), vaccine was useful in protect oneself against flu
(43.1 %), flu shot had additional benefits, e.g. protect
family member (23.5 %), perception of not having very
good or good health (16.3 %) and eligible for free gov-
ernment vaccine (10.46 %). More than half (53 %) of
these 156 people received their influenza vaccine at Gov-
ernment public clinics, and most of the remaining
(41 %) at private general practitioners.
Discussion
This is a case–control study with vaccination status as
the ‘outcome’ and personal or external environmental
factors as ‘exposures’. A case–control study design was
chosen because of a low prevalence of eligible cases. A
street intercept interview method enabled the inter-
viewers to screen and approach a larger number of
people, according to the outward appearance of their
age. This probably lowered the rejection rate and en-
abled a greater control in completing the questionnaire.
It was estimated that a larger number of people would
have had to be approached should a telephone or post-
age survey been used. The low response rate (41.7 %)
was attributable to the difficulty in finding cases, as the
excess controls approached by the interviewers were
counted as non-responders. Moreover, the interviews
were conducted in summer time when the street
temperature was >30 °C, the streets were crowded and
no incentive was offered.
Multi-dimensional factors have contributed to people’s
choice of whether or not to receive vaccination. These
factors comprise of social, environmental and economic
dynamics in a specific context. The factors were put in a
multiple logistic regression model and statistically ad-
justed for age, employment status, in receipt of social se-
curity, and all independent variables. Before statistical
adjustment, most of these factors had statistically signifi-
cant crude odds ratios. The variables affected each other
and many became non-significant after adjustment.
There would be a confounding effect between variables.
Discussion on study results
The majority of the cases (80.8 %) and controls (93.9 %)
were not aware that they were in a group recommended
by the health authority to receive influenza vaccination.
Among the controls, a higher percentage (71 %) deemed
vaccination to be ‘unnecessary’. This revealed a failure of
DH and health professionals in communicating the mes-
sage that ‘vaccination is recommended’ to this age
group. Given that there was an association between
‘knowing oneself to be in the recommended group for
flu vaccine’ and vaccination, better communication of
the risks might have improved the vaccination rate. A
health promotion strategy on empowerment and en-
hancement of knowledge on this issue needs to be
planned and supported by health-care policy.
Studies suggested that previous influenza vaccination
was a predictor for subsequent vaccination (OR 1.62-
5.40) [19–22]. However, past behaviour does not provide
an insight into the reasons why a person chooses to be
vaccinated.
The vaccination coverage rate is price sensitive. This
was demonstrated in this study and in countries which
provided vaccine reimbursements to users [23, 24]. To
receive influenza vaccination, most (95 %) people aged
50–64 years in the general Hong Kong population had
to pay out-of-pocket. In this study, the odds of the cases
being ‘eligible for free government vaccine’ were 6.4
times the controls. Among the cases, half (52 %) of them
attended a private clinic or hospital and paid the vaccin-
ation fee. Many study cases and controls expressed they
were willing to receive the vaccine if it was free or subsi-
dised. Such a vaccination service could possibly increase
the vaccination rate.
There was only a mild association between chronic
disease(s) and vaccination and the association was insig-
nificant after the OR was adjusted (OR1.13, 95 % CI
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0.65-1.96, p = 0.67). This result contradicted the findings
of many studies that indicated that the presence of
chronic diseases was one of the most persistent factors
associated with vaccination [19, 20, 25–30].
‘Accept advice by health professional’ was moderately as-
sociated with vaccination (OR2.67, 95 % CI 1.19-5.99, p =
0.02). Several other studies have shown that doctors’ and
health professionals’ advice was associated with influenza
vaccination [17, 31]. Health professionals had a duty to
recommend vaccination to high-risk groups in order to
protect them from influenza and severe complications.
‘Had family member received flu vaccine’ was associ-
ated with people’s uptake of the vaccination, but ‘accept
advice from relatives and friends’ was not. In Japan, ad-
vice from health professionals, family and/or close
friends was strongly associated [17]. In the USA and
other western countries, advice from family and/or close
friends was not a significant factor in acceptance of in-
fluenza vaccination [32, 33]. This could possibly be due
to the differences in cultural backgrounds between indi-
viduals in these countries.
This study showed no association between vaccination
and smoking and drinking. It is uncertain whether
people were consistent in their health behaviours. Stud-
ies have proven that smoking is not associated with vac-
cination [21, 34]. No data was found on other health
behaviours, such as drinking or frequent exercise, having
a link to vaccination.
Given past experiences of infectious disease epi-
demics in Hong Kong, people may be more inclined to
receive vaccination to protect themselves in anticipa-
tion of the occurrence of a disease epidemic such as
SARS or swine influenza.
Discussion on vaccination policy
Previous research has suggested that newly issued recom-
mendations are not quickly embraced by the majority of
citizens. In the US, government National Health Interview
Survey data did not show a marked increase in vaccination
rates among adults aged 19–49 and 50–64 years after the
US Advisory Committee on Immunization Practices ex-
panded its recommendations to these subgroups in 2000
and 2010, respectively [31, 35].
This vaccination policy limited the government vaccin-
ation free service to those suffering economic hardship
and chronic diseases among 50–64 year-olds. Although
the price of receiving an influenza vaccination consti-
tutes a minute percentage of monthly income, this does
not necessarily mean socio-economically deprived
groups who are ineligible for free vaccination would be
willing to pay for the vaccine. Subsidised vaccination
would attract those who are willing to pay at a dis-
counted price. Health providers could be engaged, with
or without incentives, to promote the benefit of
vaccination. In addition, DH should consider health pro-
motion messages addressing factors with strong associa-
tions to encourage payment by the individual. These
factors included ‘the perception of having severe or
moderate symptoms when contracting flu’, ‘knowledge of
being in the recommended group for flu vaccine’ and
‘good vaccine protection for healthy adults’.
Discussion on study strength and limitations
A case–control design enabled the measurement of
many different exposures at once and for the combined
effects of exposures to be examined. In addition, data
were collected within a short time-frame. One of the im-
portant limitations of this case–control was the temporal
sequence and reverse causality. It is difficult to interpret
the time sequence of the exposures and the outcomes.
For example, it is uncertain whether perception of the
safety of the influenza vaccine was a cause or a conse-
quence of vaccination. Other limitations of this case–
control include the information and recall bias of the
respondents, and the inability to estimate the coverage
of vaccination in this age band.
One limitation of using the street-intercept method
would be the possibility that the interviewers approached
those who looked 50–64 years and, potentially missed a
number of younger and older looking individuals; the ex-
tent of this bias is difficult to assess. Another bias would
be due to the sampling of respondents from different loca-
tions, e.g., on public and private estates, in train stations
and shopping malls. A comparison of the demographic
characteristics of the samples collected in different loca-
tions, and those of the relevant population, would be use-
ful to identify potential bias.
The study results have important implications for the
general population aged 50–64 years in Hong Kong.
There would be considerable differences between cul-
tures, beliefs, norms and external environments - such
as health systems and service provision - which have to
be taken into consideration when applying the results to
other populations. Further studies on the local vaccin-
ation policy and the views of health professionals would
provide a comprehensive account of the low vaccination
coverage in this age group.
Conclusions
Factors related to free and convenient vaccination, per-
ception of the severity of symptoms when contracting
influenza had a comparatively strong association with in-
fluenza vaccination uptake among 50–64 year olds, com-
pared to other factors.
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